Identification in drug quality control and drug research

被引:26
|
作者
Goeroeg, Sandor [1 ]
机构
[1] Chem Works Gedeon Richter Plc, Budapest, Hungary
关键词
Biotechnological product; Bulk drug; Degradant; Drug counterfeiting; Drug formulation; Drug quality control; Drug research; Identification; Impurity; Natural product; NEAR-INFRARED SPECTROSCOPY; HERBAL DIETARY-SUPPLEMENTS; CHINESE MEDICINE FORMULA; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; DEGRADATION-PRODUCTS; FORCED DEGRADATION; PHARMACEUTICAL IMPURITIES; COMBINATORIAL CHEMISTRY; COUNTERFEIT VIAGRA(R);
D O I
10.1016/j.trac.2014.11.020
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Identification is an important step in the quality control of drugs and the research for new drugs. First, this review discusses the identification of bulk drugs and the active ingredients in formulations, based mainly on pharmacopoeial tests. The most important methods for this purpose are infrared (IR) and, to a lesser extent, ultraviolet (UV) spectroscopy, as well as retention matching with standards using high-performance liquid chromatography (HPLC) and thin-layer chromatography (TLC). The identification of impurities and degradants is based mainly on HPLC-UV, HPLC-mass spectrometry (HPLC-MS) and nuclear magnetic resonance (NMR) spectroscopies. The above methods are also used for identification purposes in drug research. The use of MS and NMR in the research for large-molecule drugs of biotechnological origin and natural products, mainly of plant origin, with special respect to traditional Chinese (and Indian) medicines is also discussed. The review concludes with the identification aspects of the fight against counterfeit drugs. (C) 2014 Published by Elsevier B.V.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 50 条
  • [21] Drug history taking, identification of drug therapy problems and quality of patients own drugs (PODs)
    Fridriksdottir, Asta
    Gunnarsdottir, Anna I.
    Gudmundsdottir, Thorunn K.
    Almarsdottir, Anna B.
    PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 95 - 95
  • [22] DRUG IDENTIFICATION
    POLLAK, H
    NEW YORK STATE JOURNAL OF MEDICINE, 1963, 63 (17) : 2577 - &
  • [23] DRUG IDENTIFICATION
    BROZEK, CJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 228 (11): : 1371 - 1371
  • [24] DRUG IDENTIFICATION
    ROBERTSON, WO
    LANCET, 1975, 1 (7912): : 930 - 930
  • [25] DRUG IDENTIFICATION
    SOMERVEL.J
    MAYER, P
    BRITISH MEDICAL JOURNAL, 1969, 1 (5642): : 516 - &
  • [26] DRUG IDENTIFICATION
    ROBERTSON, WO
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 220 (05) : 731 - +
  • [27] Drug 'Control' or Drug 'Fixing'
    Thakre, Rhishikesh
    Patil, P. S.
    INDIAN PEDIATRICS, 2018, 55 (07) : 619 - 619
  • [28] Quality databases for rationalizing drug research and development.
    Prous, JB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 21 - CINF
  • [29] Identification of oxadiazoles as new drug leads for the control of schistosomiasis
    Sayed, Ahmed A.
    Simeonov, Anton
    Thomas, Craig J.
    Inglese, James
    Austin, Christopher P.
    Williams, David L.
    NATURE MEDICINE, 2008, 14 (04) : 407 - 412
  • [30] Identification of oxadiazoles as new drug leads for the control of schistosomiasis
    Ahmed A Sayed
    Anton Simeonov
    Craig J Thomas
    James Inglese
    Christopher P Austin
    David L Williams
    Nature Medicine, 2008, 14 : 407 - 412